1 / 27

Latest Advances in COPD Medications from ATS 2013: A Comprehensive Overview

Stay informed with a detailed update on the long-acting muscarinic antagonist Aclidinium and findings from studies on combination therapies for COPD. Learn about the latest research results, emerging therapies, safety studies, and comparative analyses presented at the ATS 2013 Conference.

ebony-bowen
Download Presentation

Latest Advances in COPD Medications from ATS 2013: A Comprehensive Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Highlights From ATS 2013: An Update on Advances in COPD

  2. Goals

  3. Reports on the Long-Acting Muscarinic Antagonist Aclidinium

  4. Beier et al Results

  5. Beeh et al Report

  6. Beeh et al Findings

  7. Combination Inhaled Corticosteroid and LABA Therapy

  8. Dransfield et al Findings

  9. Abstracts From a Long-Term Safety Study of the Nebulized LABA Arformoterol

  10. Donohue et al Findings

  11. Donohue et al Findings (cont)

  12. Make et al: Results of Evaluation of Lung Function

  13. Hanania et al: Incidence of Adverse Events

  14. Hanania et al Findings

  15. Mahler et al Study

  16. Mahler et al Findings

  17. Retrospective Study Comparing Nebulized LABA With Nebulized SABA

  18. Yeaw et al

  19. Data on Emerging Therapies

  20. Wedzicha et al Findingsa

  21. Data on Emerging Therapies: Umeclidinium

  22. Challenges and Conclusions

  23. Challenges and Conclusions (cont)

  24. Abbreviations

  25. References

  26. References (cont)

  27. References (cont)

More Related